Share Name Share Symbol Market Type Share ISIN Share Description
Proteome LSE:PRM London Ordinary Share GB0003104196 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.00p +0.00% 3.67p 33,666 11:45:17
Bid Price Offer Price High Price Low Price Open Price
3.50p 3.84p - - -
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 3.4 -2.1 -0.9 - 10.81

Proteome (PRM) Latest News

More Proteome News
Proteome Takeover Rumours

Proteome (PRM) Share Charts

1 Year Proteome Chart

1 Year Proteome Chart

1 Month Proteome Chart

1 Month Proteome Chart

Intraday Proteome Chart

Intraday Proteome Chart

Proteome (PRM) Discussions and Chat

Proteome Forums and Chat

Date Time Title Posts
27/5/201806:10Proteome Sciences leading Alzheimer's technology.78,669
24/5/201800:29Proteome, what next? (moderated)54,040
28/11/201711:40Only worth 3p on fundamentals....7
30/10/201721:22The Friends of Richards thread66
05/6/201715:59The useful PRM thread9

Add a New Thread

Proteome (PRM) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Proteome trades in real-time

Proteome (PRM) Top Chat Posts

Proteome Daily Update: Proteome is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker PRM. The last closing price for Proteome was 3.67p.
Proteome has a 4 week average price of 3.64p and a 12 week average price of 2.88p.
The 1 year high share price is 5.25p while the 1 year low share price is currently 2.70p.
There are currently 294,648,723 shares in issue and the average daily traded volume is 39,617 shares. The market capitalisation of Proteome is £10,813,608.13.
saul goodman: Hahahahahaha - I note that it is 1999 all over again on iii! 10:36 John Hopkins Cancer Test "breakthrough"...i network This present news headline sounds like it depends on proteomics tests as well as genetic tests. I would think this could have significant impact on proteomic testing sales and services/ Why is this not affecting PRM share price?? ---------------------------------------------------------------------------------- 12:30 Hold Re: John Hopkins Cancer Test The Potter I also recently read an article on Sepsis, where biomarkers were found to give the best indication of the presence of this illness. I suppose that the share price Is unaffected by these news items, because many investors do not understand the possible implications, and those that do, are awaiting for news of profitability (promised in 2018). TP
pools2: With Proteome Sciences now a GCLP accredited company, many many more doors are now open to them, which were firmly closed before. Do not underestimate the significance of the new accreditation and the additional business it will bring. PRM share price will go up and up from this current level. No additional funding will be needed and the company will be in profit next year.
tyum: BUY BUY BUY PRM share price is going up from here. Good news is coming. Buy at 4p while you can.
badger60: No they don't. People are far more interested about your cartel's intention to use questionable market manipulation to ramp up the PRM share price.......
dunderheed: Good evening gentlemen. Whilst we call await becoming millionaires in line with prm share price may I suggest a competition to guess the share price on 31.12.2017. I am coming kn with a possibly optimistic 54 gpb. I base this on a hypothesis that a deal it t/o is likely to happen with a large American company later in the year. I don't want to give too much away but I think the letters G and E are included in the name of company. All imho. Jt could you add this message to the header and maybe start a list of suggested share prices please? Thanks very much and have a Good night all.
saul goodman: This beaut is from 8 years ago to the day: (Name withheld in order to reduce acute embarrassment to anyone associated with the avatar) 9 May '09 - 09:48 - 47364 of 53733 0 0 PRM Summary - 8 May 09 [ Posted particularly to answer the question from MS MS regarding what happened on 13 Nov 2007?]. BACKGROUND. (This is a condensed summary of more than 50 pages of detailed research which I consider provides proof that the following explanation of the importance of 13 November 07 is correct.) We know, from the specific reference to strategic alliances in the Annual and Interim Reports in 2002, 2003 and 2004 and the related events beginning in the spring of 2003, that PRM had first a partnership with Amersham (for the Sensitizer, which was originally expected to make PRM profitable in 2003) and then a major strategic alliance (secret NDA) with GE which came into effect on completion of their takeover of Amersham in April 04. That strategic alliance resulted in GE taking over the commercialisation of PRM’s IP (in GE’s name) on the basis that GE would make a takeover offer - for which PRM would recommend acceptance – immediately PRM became profitable which was then confidently expected the following month. The price at which the takeover offer would be made would be based on GE’s standard formula for companies which had not yet become profitable – namely X3 the average share price over the preceding 3 years. That was arranged in December 2003 when the PRM share price was already well over £2 and expected to rise sharply before they became profitable and so to have resulted in a bid at the agreed value of around £5. But those plans were stymied in early May 04 by the ABI announcement of their iTRAQ which led to a patent issue which, in turn, led to the subsequent delays. That patent issue only became finally due to be settled on 13 November 2007 with the grant of the US TMT patent on that date. Meanwhile, the confident tone of PRM’s Reports suggested that GE has been making good progress with the commercialisation of PRMs IP. But PRM, bound by the secrecy clause in their strategic alliance NDA, was not (and is still not) allowed to announce details of that progress. In consequence the lack of real news (for several years) had resulted in the share price continuing at such a small fraction of PRM’s increasing value that (to protect its shareholders from a very low takeover price) PRM had no option but to delay PRM becoming profitable. Meanwhile, the progress on developing the value of PRM’s IP, with GE’s assistance, was steadily further increasing PRM’s value above that £5 level – as indicated on the PRM website with several products moving from “long term” towards “near term” and by the grant of the 350 patents etc mentioned in the PRM Reports. The planned TMT licence deal was with GE, who had already arranged a sub licence with Thermos Fisher (which had its origins in the deal being negotiated with Thermo Electron by Amersham in late 2003). That direct licence deal would have made PRM profitable on 13 November 2007 and triggered the agreed takeover offer bid. But the low share price meant that offer would have been below £2 per share compared with around the £5 per share originally agreed and intended - but which many shareholders would have accepted, even without PRM being compelled, by the original NDA, to recommend it. [Few shareholders seem to have taken advantage of the excellent estimates by xxxxxxx of the value to PRM of the various parts of its IP, or of the Summaries I posted of them. Many posters appear still to remain completely ignorant of where the share price should be in relation to PRM’s increasing value.] Around November 2007 our CEO, in a reported statement, assessed the value of PRM at nearly £14 per share. BUT because of his agreement to that takeover price formula in the original NDA, PRM would have had to recommend a takeover share price of under £2. That deal was NOT completed. .. WHY NOT? Our CEO was reported to have said that he hoped that shareholders would be pleased with the deal he had done instead It seems obvious that our CEO had managed to persuade GE to amend the original NDA to release PRM from GE’s stranglehold of the original takeover terms agreed four years previously – but still, I now believe, leaving the PROFITABILITY deadline in place to trigger the BIG announcement I have forecast. ----------------------- That, MS MS, is the answer to your question. Events on 12/13 November 2007 dramatically altered the future for us shareholders. We are now assured of a takeover at a price at least £5 per share and probably nearer double that. Meanwhile, as I have already recently posted, the loan conversion provides the directors with the potential ability to hold 29.74% (FD by all options etc) which together with friends appears to amount to around 53% control of PRM. That means that our CEO can now dictate the takeover terms and has a poison pill against low bids. As regards PRM’s finances, anyone who thinks there is, or ever has been, any real problem needs their head examined. You may perhaps ask: “What was that deal that our CEO did with GE?” To anyone who has not done very detailed research on all the events over the last seven years, it may be difficult to guess. But the recent amendments to the PRM website have, as I recently posted, confirmed that my guess about that new deal has been correct. But I do not think that PRM and GE would like it publicised at this time. I will however point out that (as is indicated by PRM apparently not even yet accepting the full down payment on signature from the TF) PRM appear STILL to be doing their best to delay becoming profitable. That accounts for the delays of the last many months – during which the PRM value has continued increasing since his reported statement. The future for PRM looks brilliant I confidently repeat that I believe £5 per share is now a guaranteed minimum. I again confirm that none of my information on which I base all the above has come from either GE or PRM – other then what has been already in the public domain. I also stress that all above is IMO and that you must DYOR Regards to all LTHs, xxxxx PS Edited 25 June 09.
ih_433513: Richard won't be playing as he's been saying for years that there's no need for any further fund raisings - the company can survive on fresh air alone forever. One day of course he might be right about something but as he's already an octogenarian the odds are pretty unlikely. The Dawsons were of course rather poor runner ups to the Barkers in the final of Ask the Family back in the 70s. There's a pic of the dapper family in the link - I think he's the guy on the right - and the tragic final score is shown at the bottom of the link. I gather the runners up all got mugs with their names engraved on them. He probably still chokes on his coffee from that mug every morning when he turns on the teletext to see the PRM share price. hxxp://
golly blackwell: Indeed and who can ever (or would want to) forget bullsh1t like this, that was his stock in trade. 28-04-08 The future PRM.L 6 About three years ago a friend of mine “x” who works in the city advised me to buy PRM. Another friend of mine “y” (who is a scientist and understands what the company are doing) did likewise. We have not been at all pleased with the result. But then, immediately the Thermos Fisher deal was announced “x” rang up both me and “y” and urged us to buy more – which we did. Feeling very fed up with the result, I yesterday persuaded “x” to come and explain to us both what the hell was happening and why he had been so wrong. The result is that we all will be buying more – on the basis that we believe we shall make 10 – 20 times our money in the coming weeks or months. “x” explained that the fall in the share price was mainly due to a remarkable coincidence, The manager of a fund had been sacked around that time and all the shares held by his organisation had been thrown onto the market simultaneously – not only nearly three million of PRM but all the others they had held of similar companies too. It was that, probably helped by a certain stockbroker firm and other bashers and the market generally, that had caused the fall. Otherwise he felt sure that the price would have gone strongly north. “y”, my scientist friend, and “x” then had a lengthy discussion about the future prospects for PRM. Not being technical, I listened intently to the reasons why they thought the share price could multiply by 20 and summarise my understanding as follows. As soon as the big seller is finished (which they thought was likely very soon now) the price should start recovering – because it is such an obvious “buy” as indicated by Blue Oar and Landsbanki on the TMT deal alone – particularly when they wake up to the even greater value of some of the other IP owned by PRM. Alzheimer’s, on which “x” said a deal was done with Amersham/GE in April 04, appears to be making excellent progress and could become extremely valuable. HIV/AIDS, in which Intronn now has an interest in the cure being developed by VIRxSYS could be worth even more to PRM, and the SMaRT technology seems to be going ahead well. Cancers. Although promised, we have never had more information on the JY announced nearly four years ago. HTS. We have not been informed of any failure on the tests and can therefore expect the forecast licence deals with around 20 companies to be announced soon. ProteoShop. Enormous potential value and already generating increasing revenue. vCJD. Now believed to be “near term”. Sanofi. A possible bonus of up to £23 million. Meanwhile, it seems almost certain that PRM will become a profitable company this year. A point they made is that everyone seems to be concentrating on the figures missing from the TMT dead and ignoring the broader picture. A takeover, in due course, seems inevitable – perhaps with different companies bidding for different parts of the IP such as the Intronn holding. I asked whether PRM had a collaboration agreement with GE and whether GE would take them over. “x” said that Amersham did have an agreement to make a takeover offer for PRM under certain conditions in late 03, which GE took over in April 04, but that that agreement was cancelled last year. Until then GE had been helping (handling) the commercialisatin of PRM's IP. They discussed whether TF might now want to take PRM over. Both “x” and “y” are confident that there will soon be an announcement which will indicate the enormous value of PRM’s IP, and the other companies involved – for example with the JV for the cancers. I now share their optimism that we are on to a 10 – 20 bagger. I am not technical enough, or sufficiently well informed, to answer questions on the above. I am merely reporting my understanding of what they indicated. ________________________________________
stocktastic: peverill 'look at the price over the last few weeks' there's a pending fundraiser I don't believe there is anything worsened at the company - things remain on track for 2016 and beyond. Stroke was delayed and TauRx generated results that have reduced expectations from CK1d. Later starting H1 contracts also meant the H1 growth was not as great as it would have been. As I have suggested several times a) what has materially worsened since pre-results? The revenue growth and cash burn decrease was in line with any expectations I have seen posted, including my own b) what do you suggest has 'gone wrong' over the last few weeks. The simple answer is that we have always been at the mercy of a fundraiser if a CK1d deal didn't come through/ if expectations of that weren't high. melodrama 'The share price of PRM and the volume which accompanies said share price moves is all that matters, short and long term.' You are talking nonsense and missing the point. A short term share price does not matter to most as I said. The reason being that this is not a high liquidity traders stock. If PRM moves to profitability, then the share price will find a new level, whatever it is this week. The price right now does not (other than dilutive impact in a fundraiser etc) affect what price will be seen a year from now. In light of that, it would seem that you're the one being naive. I don't support the board particularly and have long been critical of CJP and others, so your remarks are daft. In terms of Haigh, I see no reason to criticise him before giving a chance to do what he is setting out to do. What you miss, is that the company is no worse than when Haigh came in. The share price does not reflect the company, because the market does not know the company's outlook. I posted views to Pram before the results and he would be able to confirm that the way I saw the company then, is exactly as I see it now. The reality is that a few others have come around to that understanding. To give one quote 'The business is actually doing ok. It's more that slow and steady growth isn't what most want and until we're profitable, there'll be fundraisers.' You remark about views on PRM's strategies, but I'm not sure you necessarily get what it has been that PRM was trying to do and why. I've always felt Sens-It-Iv was a no hoper and explained to CJP that the volumes of animal testing were insignificant... that the pharma side of that would need too much validation. At the same time though, one can see that Sens-It-Iv was largely grant funded and that partners were hoped to take products to the next stages. Haigh seems to be doing the right thing - focusing on the projects that can generate returns. Cutting costs elsewhere. If you don't understand my views, then I suggest you may not understand the company or its projects enough. Still, you're welcome to provide rational explanations and we can see if those hold up.
golly blackwell: The Gulpster - 11 Sep'08 - 16:19 - 40270 of 40293 Peter Snodgrass - 13 Mar'06 - I think you will find, on the basis that the deal was finally agreed between all the parties on 19 Feb, that the trading on 20th (partly - perhaps mainly?- from US) indicated that the rumours had become quite widespread. Peter Snodgrass - 13 Mar'06 - ....on the basis that the deal was finally agreed between all the parties on 19 Feb, that the trading on 20th (partly - perhaps mainly?- from US) indicated that the rumours had become quite widespread....It is the delay in the announcement of signing that has allowed the shorters to cause the price to drift since. But I believe that the deal has effectively been done, and that the delay in announcing it has been due solely to the US procedures that have to be completed first.... Peter Snodgrass - 23 Oct'06 - ....Probable sequence of events....announcement of any deals (TMT?) that make PRM profitable will be followed by:- (a). A sharp rise in the share price augmented by shorters closing. (b) An announcement of the link up with GE. (An even bigger rise?) (c) A statement of all the developments – at least regarding commercialisation – that have resulted from the collaboration with Amersham / GE Healthcare during the last three years. (Yet a further rise.) OR - ? – AND THEN (d) HOPEFULLY. GE making a substantial injection of funds, at a premium to the present price (like Aventis did) to take a major stake in PRM and also announces JVs for oncology etc. and the probably already agreed (?) licences for Alzheimer’s, partnership for TMT, etc. This could include GE acquiring the 18m shares from Sanofi/Aventis. (e) PROBABLY. GE offers a partnership (as recently with another company) based on either a current valuation or on a multiple of an average share price. (f) POSSIBLY. GE making a takeover bid at an agreed price – based on valuation but perhaps (like with the Swedish biotech company) a multiple of the average share price. (g) ALTERNATIVELY. A series of JVs for various parts of PRM’s IP. I cannot foresee any other options. The only question is WHEN? But the rumours of “during the next four weeks” are the strongest I have ever heard. Peter Snodgrass - 20 Nov'07 - We all, I think, expected the announcement of the TMT deal last Tuesday - and those that had followed my takeover theory expected the takeover bid to follow. Peter Snodgrass - 21 Nov'07 - ...I suggested, based on similar previous events, that it should not take more than a week. so I would not be surprised to see the announcements even today or tomorrow....But if is not by tomorrow morning, then the US holiday would probably delay them until next GE theory is correct (ie IMO/DYOR) - what investors do not seem to realise is the enormous, and instant, impact these unexpected announcements seem likely to have on the share price - all of the last four years of progress and the true value of PRM's IP being publicised in one BIG BANG! Peter Snodgrass - 23 Nov'07 - "today/Monday morning" fits in with rumours I have heard that PRM are working very hard indeed to get the BIG announcements out without further delay goatherd - 10 Dec'07 - .....Several people have suggested TMT alone should take the price to 80 to 100p. Peter Snodgrass, who has a theory which explains much of what has happened over the years, believes a minimum price of £5 is likely after a flurry of news around the time of the TMT news..... Peter Snodgrass - 19 Dec'07 - ....Amersham is now part of GE Healthcare so it is GE who hold the 50% TMT....the estimate value of £12 per share has also reached me from two other (reliable) sources. Peter Snodgrass - 27 Dec'07 - ....CEO is reported to have said that the value within PRM is such that the share price should be over £12......done my homework VERY thoroughly over the last 12 years I agree with him Peter Snodgrass - 27 Dec'07 - .....I do not consider a share price exceeding £8 to be impossible by the end of January.... Peter Snodgrass - 28 Dec'07 - IMO/DYOR I am going to suggest that anyone investing in PRM at this price level cannot fail to see a huge profit within a few weeks and perhaps only days......Furthermore, those who have acted on my suggestion and bought (at whatever price and whenever) AND HELD ON are shortly going to be rewarded with a very handsome profit on their original investment.....we have a clear indication of the time scale relating to the news that will transform PRM and reveal its true value......investors who take advantage of this “quiet” period to accumulate PRM shares at this level cannot fail to see their investment multiply in value when the BIG news arrives in the New Year.............our CEO is reported to have valued PRM at over £12 per share – and that was before the implications of the grant of the TMT patents were fully appreciated..... Peter Snodgrass - 28 Dec'07 -....PRM is effectively backed by over £50 million cash.....It is one of the safest, most solid investments you are ever likely to find - far safer, for example, than many banks......the potential for the price to multiply, perhaps even in the next month or two, by five, ten or even twenty times is the best I have yet seen in my 70 years of investment experience. Peter Snodgrass - 31 Dec'07 - should be warning the shorters that they are ALREADY in danger of going bankrupt.....That danger is real – and imminent....VIRxSYS.....PRM may get, any day now, the injection of around $1 billion cash (or assets of similar value) resulting from that takeover.....The promised TMT deal....will instantly turn PRM into a profitable company........TMT deal is expected to be followed by at least one comprehensive broker’s report which seems likely to confirm the CEO’s reported estimate that PRM is worth over £10 per share......The cash situation and consequently the share price, are just about to be transformed – greatly to the benefit of all LTHs. Peter Snodgrass - 31 Dec'07 -.....You, and others, appear not yet to have realised that the takeover price is now pretty certain to be over £8 per share - and probably within a couple of months. Peter Snodgrass - 2 Jan'08 - some "sensible posters" are too dim to understand the blindingly obvious.....shortly get proof of my theory via GE taking Intronn (either in cash or in part exchange) and handing back to PRM most of the rest of PRM's IP....will result, probably quite soon, in the true value (well over £8 - probably £12 - per share) of PRM becoming apparent - resulting in a takeover auction for PRM which I expect GE to win. Peter Snodgrass - 2 Jan'08 -.........356_tadpole - 19176 - "how long do you suppose it will take to get to £10 a share?" and "do you believe we could be waiting another five months for CJP to give us the news of a deal?"...........Possibly to £10 by later this month - if not then February at the latest....But it is the effect of the BIG deal (and one or more comprehensive brokers reports) that will cause the leap in the share price. Peter Snodgrass - 2 Jan'08 - .....I have published estimates of the true value of PRM's IP to be at least around £8 per share (which figure was also discussed back in early 2004 on this bb). Our CEO is reported to have estimated the value to be over £12 per share early last year and my research suggests that figure to now be conservative.....I have reason to believe that the true value of PRM will be disclosed when the TMT deal is announced (any day now) via a brokers circular and by the company. I expect these to show that the present price is utterly due course, but perhaps quite soon - there will be a takeover of PRM at a price nearer its true value. I have been wrong in my timing - but we now have a deadline that is unlikely not to be met. Peter Snodgrass - 3 Jan'08 - ........PRM will shortly be groomed for a takeover......I am convinced that any figure below £5 per share would be very strongly resisted by PRM and that a value in excess of £8 seems certain. The reported estimate (early last year) by our CEO of over £12 per fully diluted share seems more likely.....In consequence I believe that we are going to see the price multiply by over ten times........ Peter Snodgrass - 5 Jun'08 - soon as PRM becomes profitable (which it probably is already but cannot yet announce it) then there will be a takeover bid at a large multiple of the present price.....likely to end up well in excess of £5 per share..... Peter Snodgrass - 7 Jan'08 - .....I now believe that part of GE Healthcare will be injected into PRM.... Peter Snodgrass - 19 Jan'08 - .....I expect, any day now, the announcement of the NEW agreement with GE which is going to startle most investors...... Peter Snodgrass - 19 Jan'08 - .....I have strong reasons for believing that the PRM value exceeds £8 per share.....I think that it probably exceeds £12 per share..... I expect an announcement of the TMT licence within days.....I expect an announcement (re GE) that will send the price towards £5 per share. ....any day now.....but.....not counting on it.....pretty certain that PRM will receive a takeover bid in excess of £8 per share (possibly £12 or more) within a couple of months...... Peter Snodgrass - 21 Jan'08 -.....I expect you to get proof, in the near future.....regarding GE's involvement with PRM.....Maybe even this week.... Peter Snodgrass - 21 Jan'08 - .....that method of investing enabled me to turn £32,000 into over £7 million in ten years. Yet none of the investments I used then had such great short term POTENTIAL as PRM obviously has now..... research has convinced me that the demand for PRM’s IP will result in a takeover at a large multiple of the present price.... Peter Snodgrass - 26 Jan'08 - In the same way that PRM invited an auction for the TMT licence (merely to get a better price than GE were originally offering) so PRM itself is shortly going to advertise its value and invite a takeover auction for the company - which I expect GE to win - at a large multiple of the present price....I expect that VALUE (over £8 per share) to be publicised during the next few days - together with the TMT licence deal. Peter Snodgrass - 29 Jan'08 - Some shareholders seem to be expecting only the announcement of the TMT deal. But the new agreement with GE must also be announced.........I therefore expect a blockbuster announcement of the new GE/PRM agreement simultaneously with TMT and accompanied by a full blast of publicity – brokers’ reports, press releases, and media interviews.......That will reveal all the progress made in the last five years and result in an immediate enormous jump in the share price - way in excess of most investors’ current expectations from just the TMT deal....So - any day, any time, now.....few - if any - intending investors will be able to buy before the share price has rocketed to a multiple of its present level..... Peter Snodgrass - 30 Jan'08 - ....I expect the next PRM announcement to provide the proof that I have been right about the GE involvement all along........"Over £5" does not contradict £12 or £14. The actual statement attributed to our CEO was "£2 billion total value". In the context of that sentence "over £5" seemed more appropriate.... Peter Snodgrass - 24 Feb'08 - ...if the announcement of the TMT deal is followed (as I expect) by revelations about what has really been going on behind the scenes (and increasing the value of PRM) for the last four years, then the current price seems (IMO but DYOR) guaranteed to multiply by a greater factor than even the most optimistic shareholders expect.... Peter Snodgrass - 10 Mar'08 - ...It confirms my own view that the expected announcement (any day now?) of the TMT licence deal is likely to multiply PRM’s present price X3 almost instantly.... Peter Snodgrass - 24 Mar'08 - 13:38 - ....until we get details of the new agreement with GE we can only guess its contents. I expect it to be a temporary partnership (Option 1) to get the share price nearer to an agreed value (well over £5) - when PRM will probably then go to auction.......I expect the new agreement with GE to be announced with - or shortly after - the TMT licence deal. ......the Biofarmer suggestion (27121) of a takeover offer from ABI may liven things up! I think it would have to be way over £5 per share to be acceptable - even if GE bought the 43% Intronn separately.... Peter Snodgrass - 3 Apr'08 - ...freelance in his 28214 said that the Cubana investors " are confident of a 10 - 20 times increase on their investment.".....I also know that to be the case Peter Snodgrass - 13 Apr'08 - ....the announcement of that, including the sudden release of all the progress made over the last four years, that I expect to cause the giant leap in the share price..... Peter Snodgrass - 13 Apr'08 - Presumably because TF were a vastly better equipped company to extract maximum benefits worldwide in this field than GE Healthcare who otherwise would have been in competition with TF - which company GE probably has plans to take over. Peter Snodgrass - 21 May'08 - ....I later received information which leads me to believe that the planned publicising of the TMT deal alone may result, within a couple of weeks or so, in the share price approaching the 150p per share forecast in the Blue Oar Report dated 14 April....If the other information I listed (re Alzheimer's, HTS, etc etc) is also released then the share price should well exceed that Peter Snodgrass - 23 May'08 - ....That's fine. But what do you do when an announcement involving GE and - say - Intronn proves the old buffer to have been right and you have missed the chance to make X10 your money by not listening to him and following his line of thought? Peter Snodgrass - 26 May'08 - ....The bid will come from ABI,,,,,sooner rather than later - before, as roy123 says in 33002 - "TMT is about to EXPLODE into the market place!!" So - possibly this week?
Proteome share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V: D:20180527 21:38:13